The major difference is that EXL has revenue now .. $6 mil as of last report and already selling into Japan..QBL on the other hand has expenditure (massive) and the possibility of future equally massive revenue...QBL (IF the proposed MedCann acquisition completes) will have another major difference to EXL and that is a production & manufacture license for high THC . EXL to date has no local license, as far as I know, and produces only CBD overseas.
EXL does have their own food (seed hulling etc) production locally as well as contracted growers for organic hemp. There are more comparisons.... supplying wholesale to other Brands etc but the bottom line $$$$ is all that counts and the major differences are as I stated EXL has revenue but no local license as yet... QBL has expenditure not revenue and MAY have the licenses in the future.
- Forums
- ASX - By Stock
- CGB
- Price Estimate
Price Estimate, page-38
-
- There are more pages in this discussion • 170 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CGB (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online